Growth Metrics

Nu-Med Plus (NUMD) Shares Outstanding (2016 - 2021)

Nu-Med Plus' Shares Outstanding history spans 10 years, with the latest figure at $79.3 million for Q3 2021.

  • Quarterly results put Shares Outstanding at $79.3 million for Q3 2021, up 57.98% from a year ago — trailing twelve months through Sep 2021 was $79.3 million (up 57.98% YoY), and the annual figure for FY2020 was $51.0 million, up 14.73%.
  • Shares Outstanding for Q3 2021 was $79.3 million at Nu-Med Plus, roughly flat from $79.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $79.3 million in Q1 2021 to a low of $37.2 million in Q1 2017.
  • The 5-year median for Shares Outstanding is $41.5 million (2019), against an average of $47.9 million.
  • The sharpest move saw Shares Outstanding dropped 4.45% in 2017, then soared 78.4% in 2021.
  • Year by year, Shares Outstanding stood at $37.6 million in 2017, then grew by 9.88% to $41.3 million in 2018, then increased by 7.76% to $44.5 million in 2019, then increased by 14.73% to $51.0 million in 2020, then surged by 55.5% to $79.3 million in 2021.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $79.3 million, $79.3 million, and $79.3 million for Q3 2021, Q2 2021, and Q1 2021 respectively.